Is soluble transferrin receptor a good marker of iron deficiency anemia in chronic kidney disease patients

Indian Journal of Nephrology

Volumn 19, Issue 3, 2009, Pages 96-100

  Gupta, S ^a   Uppal, B ^a   Pawar, B ^a  

^a Department of Biochemistry ^*  (India)

Author keywords

Chronic kidney disease; Erythropoietin; Hemodialysis; Iron deficiency anemia; Soluble transferrin receptor; Total iron binding capacity; Transferrin saturation

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; HEMOGLOBIN; IRON; SOLUBLE TRANSFERRIN RECEPTOR; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HUMAN; IRON BINDING CAPACITY; IRON DEFICIENCY ANEMIA; IRON METABOLISM; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; STUDENT T TEST; TRANSFERRIN SATURATION;

EID: 77953396522     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.57105     Document Type: Article

References (21)

1. Agarwal SK. Chronic kidney disease and its prevention in India. Kidney Int Suppl 2005;98:S41-S45.
2. National Kidney Foundation. Kidney Disease outcomes quality initiative: Clinical practice guidelines for anemia of chronic kidney disease. IV NKF-K / DOQI, Update 2000. Am J Kidney Dis 2001;37:S182-238.
3. Ahluwalia N, Skikne BS, Savin V, Chonko A. Markers of masked iron defciency and effectiveness of EPO therapy in chronic renal failure. Am J Kidney Dis 1997;30:532-541
4. Baillie FJ, Morrison AE, Fergus I. Soluble transferrin receptor: A discriminating assay for iron defciency. Clin Lab Haematol 2003;25:353-357
5. Miller YE, Jones C, Scoggin C, Morse H, Seligman P. Chromosome 3q (22-ter) encodes the human transferrin receptor. Am J Hum Genet 1983;35:573-583
6. Kari P, Kerttu I, Allan R. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron defciency. Blood 1997;89:1052-1057
7. Kohgo Y, Torimoto Y, Karo J. Transferrin receptor in tissue and serum: Updated clinical signifcance of soluble transferrin receptor. Int J Hematol 2002;76:213-218
8. Cazzola M, Bergamaschi G, Dezza L, Arosio P. Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: Achievements and prospects. Blood 1990;75:1903-1919
9. Chan LNL, Gerhardt EM. Transferrin receptor gene is hyper expressed and transcriptionally regulated in differentiating erythroid cells. J Biol Chem 1992;267:8254-8259
10. Available from: Www.usrds.org. US Renal data system USRDS 2003 annual data report atlas of end stage renal disease in the United States. USRDS web site. National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Disease. Bethesda, Md: 2003. p. 55.
11. Talwar VK, Gupta HL, Shashinarayan. Clinico haematological profile in chronic renal failure. J Assoc Physician India 2002;50:228-233
12. Maiz HB, Abderrahim E, Zouaghi K. Anemia and end stage renal disease in the developing world. Artif Organs 2002;26:760-764
13. Singh NP, Aggarwal L, Singh T, Anuradha S, Kohli R. Anemia, iron studies and erythropoietin in patients of chronic renal failure. JAPI 1999;47:284-290
14. Braun J, Lindner K, Schreiber M, Heidler RA, Horl WH. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance of hemodialysis patients. Nephrol Dial Transplant 1997;12:1173-1181
15. Fusaro M, Munaretto G, Spinello M, Rebeschini M, Amici G, Gallieni M, et al. Soluble transferrin receptors and reticulocytes hemoglobin concentration in the assessment of iron defciency in hemodialysis patients. J Nephrol 2005;18:72-79
16. Tarng DC, Huang TP. Determinants of circulating soluble transferrin receptor level in chronic hemodialysis patients. Nephrol Dial Transplant 2002;17:1063-1069
17. Fernandez-Rodriguez AM, Guinedo-Casasus MC, Molero-Labarta T, Domínguez-Cabrera C, Hortal-Casc n L, Pérez-Borges P, et al. Diagnosis of iron defciency in chronic renal failure. Am J Kidney Dis 1999;34:508-513
18. Tonbul HZ, Kaya H, Selcuk NY, Tekin SB, San A, Akçay F, et al. The importance of serum transferrin receptor level in diagnosis of functional iron defciency due to recombinant human erythropoietin treatment in haemodialysis patients. Int Urol Nephrol 1998;30:645-651
19. Chiang WC, Tsai TJ, Chen YM, Heish BS. Serum soluble transferrin receptor refects erythropoiesis but not iron availability in erythropoietin treated chronic hemodialysis patients. Clin Nephrol 2002;58:363-369
20. Lorenzo JD, Rodriguez MM, Martin SS, Romo JM. Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferrokinectic measurement. Am J Kidney Dis 2001;37:550-556
21. Anatole B. Evaluating iron suffciency: A clear view. Kidney Int 2001;60:2412-2414